Washington
Tempus is a biotechnology company focused on making precision medicine a reality by applying AI in healthcare, deriving insights from an expansive library of clinical data and molecular data.
Estimated valuation today
$53M
-99.38% since last round
Calculated based on estimated multiplier and revenue.
Revenue
Update this based on your knowledge or projections. Calculations use last 12 months revenue.
Hype Multiple
Currently selected comps have a median growth rate of 11.40%
This premium represents how much of a bonus the company receives on its valuation for its additional growth compared to the selected public comps. The valuation is multipled by the Hype Multiple to get the final valuation. You can read more about this from a16z.
multiple
In an event of a merger or aquisition, the investors will get their money back first. In this case, the investors got paid out first and there is no money left which means employee common stock is worthless.
The last round was 4 months ago.
Date
April 2022
Valuation
$8.5B
Amount raised
$250M
We estimate company valuation by comparing it to similiar companies in the public market. The revenue multipler is calculated by taking a company's current valuation and dividing it by its total revenue.
Multiple at last round
1.62x revenue
Today's multiple
1.64x revenue
Change
1.30%
Companies
Industry – Healthcare
Last updated 5 mins ago.
| Remove | Name | Ticker | Price multiple |
|---|---|---|---|
| Tempus | 1.64x | ||
| 1Life Healthcare Inc | ONEM | 4.38x | |
| HCA Holdings Inc | HCA | 1.04x | |
| Tenet Healthcare Corporation | THC | 0.37x | |
| Quest Diagnostics Incorporated | DGX | 1.51x | |
| Humana Inc | HUM | 0.67x |
| Date | Round | Amount raised | Price per share (Preferred) | Valuation |
|---|---|---|---|---|
| Apr 2022 | Series G-3 | $250MM | $57.31 | $8.53B |
| Dec 2020 | Series G-2 | $197.89MM | $57.31 | $8.12B |
| Mar 2020 | Series G | $97.31MM | $38.35 | $5.02B |
| May 2019 | Series F | $200MM | $24.76 | $3.17B |
| Aug 2018 | Series E | $111.02MM | $16.74 | $2.17B |
| Mar 2018 | Series D | $80MM | $9.37 | $1.03B |
| Sep 2017 | Series C | $70MM | $7.16 | $759.82MM |
| Apr 2017 | Series B-2 | $30MM | $7.16 | $584.99MM |
| Nov 2016 | Series B-1 | $10MM | $4.00 | $286MM |
| Jun 2016 | Series B | $10MM | $1.86 | $143.02MM |
| Sep 2015 | Series A | $10MM | $1.00 | $66.67MM |
With a revenue of $22M and a Hype Multiple of 1.5x,
Tempus is estimated to be worth $53M.